Effects of β-Glucan Supplementation on LPS-Induced Endotoxemia in Horses

• Published in: Animals (Basel) Vol. 14; no. 3; p. 474
• Main Authors: Lacerenza, Milena Domingues, Arantes, Júlia de Assis, Reginato, Gustavo Morandini, Passarelli, Danielle, Balieiro, Júlio César de Carvalho, Amaral, Andressa Rodrigues, Vendramini, Thiago Henrique Annibale, Brunetto, Marcio Antonio, Dória, Renata Gebara Sampaio
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.01.2024
• Subjects: Analysis; Animals; Bilirubin; Blood proteins; Body temperature; Cytokines; Dietary supplements; Escherichia coli; Females; Glucose; Heart beat; Heart rate; Hematology; Horses; Immune response; immunomodulation; Immunotherapy; Inflammation; Lactates; Leukocytes; lipopolysaccharides; Protozoa; Sepsis; Yeast; yeasts; Brazil; immunomodulation; cytokines; yeasts; lipopolysaccharides; horses
• ISSN: 2076-2615; 2076-2615
• DOI: 10.3390/ani14030474

β-glucan is part of the cell wall of fungi and yeasts and has been known for decades to have immunomodulating effects on boosting immunity against various infections as a pathogen-associated molecular pattern that is able to modify biological responses. β-glucan has been used in rat models and in vitro studies involving sepsis and SIRS with good results, but this supplement has not been evaluated in the treatment of endotoxemia in horses. This study aims to evaluate the effects of preventive supplementation with β-glucan in horses submitted to endotoxemia by means of inflammatory response modulation. Eight healthy horses, both male and female, aged 18 ± 3 months, weighing 300 ± 100 kg of mixed breed, were randomly assigned to two groups of four animals, both of which were subjected to the induction of endotoxemia via the intravenous administration of lipopolysaccharides (0.1 µg/kg). For 30 days before the induction of endotoxemia, horses in the β-glucan group (GB) received 10 mg/kg/day of β-glucan orally, and horses in the control group (GC) received 10 mg/kg/day of 0.9% sodium chloride orally. The horses were submitted to physical exams, including a hematological, serum biochemistry, and peritoneal fluid evaluation, and the serum quantification of cytokines TNF-α, IL-6, IL-8, and IL-10. For statistical analysis, the normality of residues and homogeneity of variances were verified; then, the variables were analyzed as repeated measures over time, checking the effect of treatment, time, and the interaction between time and treatment. Finally, the averages were compared using Tukey's test at a significance level of 5%. Horses from both experimental groups presented clinical signs and hematological changes in endotoxemia, including an increase in heart rate and body temperature, neutrophilic leukopenia, an increase in serum bilirubin, glucose, lactate, and an increase in TNF-α, IL-6, and IL-10. Hepatic and renal function were not compromised by β-glucan supplementation. GB presented higher mean values of the serum total protein, globulins, and IL-8 compared to that observed in GC. In the peritoneal fluid, horses from GB presented a lower mean concentration of neutrophils and a higher mean concentration of macrophages compared to the GC. It was concluded that preventive supplementation of β-glucan for thirty days modulated the immune response, as evidenced by increasing serum total proteins, globulins, IL-8, and changes in the type of peritoneal inflammatory cells, without effectively attenuating clinical signs of endotoxemia in horses. Considering the safety of β-glucan in this study, the results suggest the potential clinical implication of β-glucan for prophylactic use in horse endotoxemia.